- Precision Medicine World Conference
- January 28th, 2021
On January 26th, 2021 Dr. Steven Quay presented at the PMWC (Virtual). He spoke in the “Development of New SARS CoV 2 Therapeutics”. You can watch his segment above which is the first 21 minutes of the video.
Monica Herrera and George Carlin Yuman from Bio-Rad Laboratories introduce the session on the development of Source Code V2 therapeutics, focusing on COVID-19. Monica Herrera, Director of Molecular Diagnostics, and Dr. George Carlin Yuman, Director of Scientific Affairs, present the agenda, highlighting four topics: prophylaxis, antivirals, plasma therapy, and anti-inflammatories, with various experts in each field. They stress the urgency for more research and development due to the ongoing COVID-19 pandemic’s impact.
They discuss the pathogenesis of the disease, emphasizing the importance of early antiviral therapies and later immune modulators. They mention ongoing clinical trials and introduce speakers who discuss their approaches to therapeutics development, including Dr. Steven Quay and Dr. Ashish Manglik, who present their respective programs on prophylaxis using nasal sprays and nanobodies targeting the spike protein to prevent viral entry. They address questions on the efficacy and availability of their compounds, highlighting the potential of nasal applications for strong prophylaxis.
For more information about PMWC:
https://www.pmwcintl.com/
